BOOTS TICKLY COUGH RELIEF ORAL SOLUTION

Active substance: LIQUID SUGAR

View full screen / Print PDF » Download PDF ⇩

Transcript
SUMMARY OF PRODUCT CHARACTERISTICS

1

NAME OF THE MEDICINAL PRODUCT
Boots Tickly Cough Relief Oral Solution
Boots Dry Cough Relief Oral Solution

2

QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
Glycerin
Liquid sugar
(Equivalent to sucrose

3

per 5ml
0.75 ml
1.93 ml
1.70 g)

PHARMACEUTICAL FORM
Oral Solution

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
For the relief of irritating, tickling dry coughs and sore throats.

4.2.

Posology and Method of Administration
Adults and children over 5 years: 10 ml.
Children 1 - 5 years: 5 ml.
The dose may be repeated three or four times a day.
Children under one year: Not to be given to children under 1 year.
Elderly: There is no need for dosage reduction in the elderly.
For oral administration.

4.3.

Contra-indications
Hypersensitivity or intolerance to any of the ingredients.

4.4.

Special Warnings and Precautions for Use
Diabetics should take note of the carbohydrate contents of this product.
Do not give to children under one year.
Keep all medicines out of the reach of children.

4.5.

Interactions with other Medicaments and other forms of Interaction
No clinically significant interactions known.

4.6.

Pregnancy and Lactation
The safety of this product during pregnancy and lactation has not been
established, but is not considered to constitute a hazard during these periods.

4.7.

Effects on Ability to Drive and Use Machines
Not applicable.

4.8

Undesirable effects

4.9.

Immune system disorder: hypersensitivity reactions, including anaphylaxis.
Overdose
Overdosage would not be expected to cause any problems and treatment
would be merely symptomatic and supportive.

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties
Glycerin and sucrose have demulcent properties and will soothe irritated sore
throats and possibly block sensory cough receptors within the respiratory tract.

5.2.

Pharmacokinetic Properties
Glycerin is readily absorbed from the gastrointestinal tract and undergoes
extensive metabolism principally in the liver. It may be used in the synthesis
of lipids, and is metabolised to glucose or glycogen or oxidised to carbon
dioxide and water. It may also be excreted in the urine unchanged.
Sucrose is hydrolysed in the small intestine by the enzyme sucrase to glucose
and fructose which are then absorbed.

5.3.

Preclinical Safety Data
There are no preclinical data of relevance to the prescriber which are
additional to that already included.

6.

PHARMACEUTICAL PARTICULARS

6.1.

List of Excipients
Citric acid monohydrate
Sodium benzoate
Cough Syrup 513277
Black Treacle
Liquid glucose
Purified water

6.2.

Incompatibilities
Not applicable.

6.3.

Shelf Life
36 months.

6.4.

Special Precautions for Storage
None.

6.5.

Nature and Contents of Container
A white flint glass bottle with an aluminium roll-on pilfer proof cap with a
flowed in liner, or a triseal (LDPE/EPE/LDPE) Liner.
Alternative cap: A wadless polypropylene tamper evident cap.
Pack size: 200ml.
Or
An amber glass bottle with an aluminium roll-on pilfer proof cap with a triseal
LDPE/EPE/LDPE liner
Pack size: 125ml.
Or
An amber PET bottle with a child resistant polypropylene cap fitted with an
expanded polyethylene liner.
Pack size: 150ml or 300ml

6.6.

Instruction for Use/Handling
None.

7.

MARKETING AUTHORISATION HOLDER
The Boots Company PLC
1 Thane Road West
Nottingham

NG2 3AA
Trading as: BCM

8.

MARKETING AUTHORISATION NUMBER(S)
PL 00014/0550

9.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
13 December 1995

10

DATE OF REVISION OF THE TEXT
09/11/2011

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)